מכפיל EV/EBITDA: PetMed Express Inc. (PETS)

PetMed Express, Inc. (PETS) operates in a protected segment where demand for veterinary pharmaceuticals remains stable regardless of economic turmoil. The company's revenues are based on customer loyalty and recurring orders, with customer acquisition cost serving as a key success factor. The organization is currently transforming its services by developing telemedicine. The current EV/EBITDA ratio stands at 0.00, as clearly demonstrated by the share price chart below.

To decouple fundamental asset value from market volatility, the ratio of total capital including all liabilities to operating profit is used, allowing for an assessment of the business's real value without the influence of the tax burden. By analyzing the EV/EBITDA value of PetMed Express, Inc. (PETS) on the chart, an investor can compare the debt load of PetMed Express, Inc. (PETS) with the efficiency of its expansion into the digital veterinary subscription and online pharmacy segments.